13 reports

  • Sunesis Pharma Enters Into Licensing Agreement With Millennium Pharma
  • Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details

Summary Sunesis Pharmaceuticals Inc (Sunesis), formerly Mosaic Pharmaceuticals, Inc. develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company’s Vosaroxin is being developed in Phase III clinical trials for the treatment of acute myeloid leukemia (AML). It is a first-in-class...

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Sunesis Pharmaceuticals, Inc.
  • Sunesis Pharmaceuticals Inc - Opportunities
  • Sunesis Pharmaceuticals Inc - Strengths

Sunesis Pharmaceuticals Inc (SNSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities...

  • Pharmaceutical
  • Targeted Therapy
  • United States
  • Company Financials
  • Sunesis Pharmaceuticals, Inc.

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2016 Social Media Advertising Spend in China, 2016 Databook List of Figures List of Tables ##.

  • Advertising
  • Computer
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Brands pay for space on one or more of the online company' s pages to display a static or linked banner or logo.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • Employee Efficiency: Sunesis Pharmaceuticals, Inc.
  • Comparative Business Analysis: Sunesis Pharmaceuticals, Inc.

A textual analysis of the financial results for Sunesis Pharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including...

  • Pharmaceutical
  • United States
  • Company Financials
  • Sunesis Pharmaceuticals, Inc.
  • Employee Efficiency: Sunesis Pharmaceuticals, Inc.
  • Fixed Charges Coverage: Sunesis Pharmaceuticals, Inc.

A textual analysis of the financial results for Sunesis Pharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including...

  • Pharmaceutical
  • United States
  • Company Financials
  • Sunesis Pharmaceuticals, Inc.
  • Valuation multiples (Sunesis Pharmaceuticals, Inc.)
  • Valuation multiples (Sunesis Pharmaceuticals, Inc.)

Sunesis Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Sunesis Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers...

  • Pharmaceutical
  • United States
  • Corporate Finance
  • Sunesis Pharmaceuticals, Inc.
  • Sunesis Pharmaceuticals, Inc.: Threats
  • Sunesis Pharmaceuticals, Inc.: Threats

Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product...

  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • Sunesis Pharmaceuticals, Inc.
  • Employee Efficiency: Sunesis Pharmaceuticals, Inc.
  • Fixed Charges Coverage: Sunesis Pharmaceuticals, Inc.

A textual analysis of the financial results for Sunesis Pharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including...

  • Pharmaceutical
  • United States
  • Company Financials
  • Sunesis Pharmaceuticals, Inc.
  • AML - Late-Stage Pipeline, 2015
  • Product Profile - Qinprezo

Guadecitabine is presently in Phase III development in the US and the EU (Astex Pharmaceuticals, NCT##; ASTRAL-##) and a Phase I trial is being conducted by Otsuka Pharmaceuticals in Japan.

  • Pharmaceutical
  • United States
  • World
  • Demand
  • Sunesis Pharmaceuticals, Inc.

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2015 Social Media Advertising Spend in China, 2015 Databook List of Figures List of Tables ##.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Digital Advertising Spend in China, 2015 Databook REFERENCE CODE: DSDB## PUBLISHED: APRIL 2015 LIST OF FIGURES LIST OF TABLES ##.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • Comparative Business Analysis: Sunesis Pharmaceuticals, Inc.
  • Income Statement - (Actual Values): Sunesis Pharmaceuticals, Inc.

A textual analysis of the financial results for Sunesis Pharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including...

  • Pharmaceutical
  • United States
  • Company Financials
  • Sunesis Pharmaceuticals, Inc.